First Trust Advisors
NBP

First Trust Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

First Trust Advisors’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-92,216
Closed -$370K – 2490
2022
Q3 		$370K Sell
92,216
-4,326
-4% -$32.8K ﹤0.01% 2296
2022
Q2 		$1.09M Buy
96,542
+84,271
+687% +$1.01M ﹤0.01% 1951
2022
Q1 		$199K Sell
12,271
-570
-4% -$14.6K ﹤0.01% 2473
2021
Q4 		$609K Buy
+12,841
New +$771K ﹤0.01% 2231

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Trust Advisors's NBP Position: Q4 2022 in Review

First Trust Advisors sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2022, closing a stake of 92,216 shares — an estimated $370K sold.

First Trust Advisors first reported a position in NBP in Q4 2021 and held it in 4 quarters. The position peaked at $1.09M in Q2 2022. 69 funds tracked by Wall St. Rank hold NBP as of Q4 2022.

  • First Trust Advisors reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • First Trust Advisors sold 92,216 NovaBridge Biosciences American Depositary Shares shares in Q4 2022, an estimated $370K.
  • First Trust Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2021 and held it in 4 quarters.
  • First Trust Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $1.09M in Q2 2022.
  • 69 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2022.

Based on First Trust Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.